EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy of turmeric in systemic, topical, and combination formulation in the management of oral submucous fibrosis

Adit Srivastava, Naresh Kumar Sharma, Ganiga Channaiah Shivakumar, Sahana Shivakumar, P. G. Naveen Kumar, Thakur Prasad Chaturvedi, Akhilesh Kumar Singh

National Journal of Maxillofacial Surgery · 2026-01 · 17 (1) · 128-137

DOI: 10.4103/njms.njms_60_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift National Journal of Maxillofacial Surgery, online erschienen am 30.04.2026. Verfasst von Adit Srivastava und 6 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Oral submucous fibrosis (OSMF) is among the most common potentially malignant disorders of the oral cavity, closely linked to the habitual chewing of areca nut and tobacco. Management options range from habit cessation counseling and physiotherapy to pharmacological and surgical interventions. This study aimed to assess and compare the effects of turmeric—given orally, applied topically, or in combination—with those of a positive control (antioxidants) in patients with OSMF. Material and Methods: Ninety six clinically diagnosed OSMF patients, aged 18–50 years, were randomly assigned to four equal groups. Group A received turmeric capsules; Group B applied turmeric topically; Group C received both oral and topical turmeric; and Group D was given antioxidant tablets. Active treatment lasted three months, followed by monitoring up to six months. Monthly assessments included burning sensation, interincisal mouth opening, tongue protrusion (TP), and cheek flexibility (CF).

Results

Burning sensation was reduced notably in all groups within the first three months. Group A achieved the greatest gain in mouth opening (mean: 33.13 ± 3.56 mm, P < 0.001). Group B showed the highest TP improvement by the sixth month. CF increased steadily in Groups C and D over six months, with statistically significant results. The combined turmeric approach (Group C) demonstrated the most balanced improvement across all measured outcomes.

Conclusion

Turmeric, whether oral, topical, or both, is a safe, inexpensive, and effective adjunct for managing OSMF. Combined therapy appears to offer the most comprehensive benefit. Larger, longer term studies are recommended to strengthen the evidence base and guide clinical protocols.

Zitieren

APA

Srivastava, A., Sharma, N. K., Shivakumar, G. C., Shivakumar, S., Kumar, P. G. N., Chaturvedi, T. P., & Singh, A. K. (2026). Efficacy of turmeric in systemic, topical, and combination formulation in the management of oral submucous fibrosis. National Journal of Maxillofacial Surgery, 17(1), 128-137. https://doi.org/10.4103/njms.njms_60_25

Vancouver

Srivastava A, Sharma NK, Shivakumar GC, Shivakumar S, Kumar PGN, Chaturvedi TP, et al. Efficacy of turmeric in systemic, topical, and combination formulation in the management of oral submucous fibrosis. National Journal of Maxillofacial Surgery. 2026;17(1):128-137. doi:10.4103/njms.njms_60_25

BibTeX
@article{Srivastava2026,
  author = {Srivastava, Adit and Sharma, Naresh Kumar and Shivakumar, Ganiga Channaiah and Shivakumar, Sahana and Kumar, P. G. Naveen and Chaturvedi, Thakur Prasad and Singh, Akhilesh Kumar},
  title = {Efficacy of turmeric in systemic, topical, and combination formulation in the management of oral submucous fibrosis},
  journal = {National Journal of Maxillofacial Surgery},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {128--137},
  doi = {10.4103/njms.njms_60_25}
}
Kostenlos starten →